You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians

Article info

Article menu
XML
Cystic fibrosis
Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians

Authors

  • Grace Currie Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Anna Tai Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, AustraliaInstitute for Respiratory Health, Nedlands, Western Australia, AustraliaSchool of Medicine, The University of Western Australia Faculty of Medicine Dentistry and Health Sciences, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Tom Snelling Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, AustraliaDepartment of Infectious Diseases, Perth Children's Hospital, Nedlands, Western Australia, AustraliaSchool of Public Health, Curtin University, Perth, Western Australia, AustraliaMenzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia PubMed articlesGoogle scholar articles
  • André Schultz School of Medicine, The University of Western Australia Faculty of Medicine Dentistry and Health Sciences, Perth, Western Australia, AustraliaDepartment of Respiratory Medicine, Perth Children's Hospital, Nedlands, Western Australia, AustraliaRespiratory Health, Telethon Kids Institute, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr André Schultz; andre.schultz{at}health.wa.gov.au
View Full Text

Citation

Currie G, Tai A, Snelling T, et al
Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians
BMJ Open Respiratory Research 2021;8:e000956. doi: 10.1136/bmjresp-2021-000956

Publication history

  • Received April 9, 2021
  • Accepted May 15, 2021
  • First published July 15, 2021.
Online issue publication 
July 13, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.